163 related articles for article (PubMed ID: 29119585)
1. Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure.
Gonsai NH; Amin VH; Mendpara CG; Speth R; Hale GM
J Clin Pharm Ther; 2018 Feb; 43(1):1-7. PubMed ID: 29119585
[TBL] [Abstract][Full Text] [Related]
2. Role of dopamine in the pathogenesis of hypertension.
Jose PA; Eisner GM; Felder RA
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
[TBL] [Abstract][Full Text] [Related]
3. The dopaminergic system in hypertension.
Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
[TBL] [Abstract][Full Text] [Related]
4. Regulation of blood pressure by dopamine receptors.
Jose PA; Eisner GM; Felder RA
Nephron Physiol; 2003; 95(2):p19-27. PubMed ID: 14610323
[TBL] [Abstract][Full Text] [Related]
5. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
Amenta F; Ricci A; Tayebati SK; Zaccheo D
Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
[TBL] [Abstract][Full Text] [Related]
6. Renal dopaminergic mechanisms and hypertension: a chronology of advances.
O'Connell DP; Aherne AM
Clin Exp Hypertens; 2000 Apr; 22(3):217-49. PubMed ID: 10803730
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Millan MJ; Iob L; Péglion JL; Dekeyne A
Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
[TBL] [Abstract][Full Text] [Related]
8. The discovery of potent and selective dopamine D4 receptor antagonists.
Faraci WS; Zorn SH; Sanner MA; Fliri A
Curr Opin Chem Biol; 1998 Aug; 2(4):535-40. PubMed ID: 9736928
[TBL] [Abstract][Full Text] [Related]
9. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Trends Pharmacol Sci; 1994 Jul; 15(7):264-70. PubMed ID: 7940991
[TBL] [Abstract][Full Text] [Related]
12. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
13. Dopamine and vascular dynamics control: present status and future perspectives.
Tayebati SK; Lokhandwala MF; Amenta F
Curr Neurovasc Res; 2011 Aug; 8(3):246-57. PubMed ID: 21722093
[TBL] [Abstract][Full Text] [Related]
14. Interactions between the intrarenal dopaminergic and the renin-angiotensin systems in the control of systemic arterial pressure.
Vaz de Castro PAS; Jose PA; Simões E Silva AC
Clin Sci (Lond); 2022 Aug; 136(16):1205-1227. PubMed ID: 35979889
[TBL] [Abstract][Full Text] [Related]
15. Role of dopamine receptors in the kidney in the regulation of blood pressure.
Jose PA; Eisner GM; Felder RA
Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):87-92. PubMed ID: 11753092
[TBL] [Abstract][Full Text] [Related]
16. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptors and antipsychotic drug response.
Sunahara RK; Seeman P; Van Tol HH; Niznik HB
Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D4 receptors: curiouser and curiouser.
Strange PG
Trends Pharmacol Sci; 1994 Sep; 15(9):317-9. PubMed ID: 7992381
[No Abstract] [Full Text] [Related]
20. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
Seeman P
Neuropsychopharmacology; 1992 Dec; 7(4):261-84. PubMed ID: 1362057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
